TNF and myeloid sarcoma: In support of this, Mellergard et al. (2010) indicate that MS patients with EDSS measurements in the range comparable to the RR-MS cohort assessed in present study demonstrate no alteration in plasma TNF-α when compared to healthy subjects (Mellergard et al., 2010).